Daniel Finke
Impact in
-
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiac Fibrosis and Remodeling
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 6
- Cardiovascular Function and Risk Factors 3
- Viral Infections and Immunology Research 2
-
- Epigenetics and DNA Methylation 2
- Glycosylation and Glycoproteins Research 1
- Co-authors
- Lorenz Lehmann (17 shared papers)Markus Heckmann (12 shared papers)Hugo A. Katus (9 shared papers)Florian Leuschner (3 shared papers)Uwe Haberkorn (2 shared papers)Norbert Frey (9 shared papers)Esther Herpel (2 shared papers)Hauke Hund (5 shared papers)
- Journals
- ESC Heart Failure (3 papers)Clinical Research in Cardiology (2 papers)Journal of Molecular and Cellular Cardiology (1 paper)Frontiers in Cardiovascular Medicine (1 paper)Cytometry (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Daniel Finke
18 papers receiving 408 citations
Peers
Comparison fields: 5 of 47
- Oncology 185
- Cardiology and Cardiovascular Medicine 148
- Cancer Research 49
- Radiology, Nuclear Medicine and Imaging 71
- Surgery 84
Countries citing papers authored by Daniel Finke
This map shows the geographic impact of Daniel Finke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Finke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Finke more than expected).
Fields of papers citing papers by Daniel Finke
This network shows the impact of papers produced by Daniel Finke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Finke. The network helps show where Daniel Finke may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Finke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 104 | |
| 2 | 2021 | 76 | |
| 3 | 2018 | 32 | |
| 4 | 2021 | 31 | |
| 5 | Multiparameter assessment of the cell cycle effects of bioactive and cytotoxic agents. | 1992 | 27 |
| 6 | 2021 | 25 | |
| 7 | 2021 | 21 | |
| 8 | 2024 | 19 | |
| 9 | 2019 | 13 | |
| 10 | 2019 | 13 | |
| 11 | 2020 | 11 | |
| 12 | 2022 | 10 | |
| 13 | 1992 | 10 | |
| 14 | 2023 | 8 | |
| 15 | 2021 | 7 | |
| 16 | 2022 | 1 | |
| 17 | 2024 | 1 | |
| 18 | 2024 | 1 | |
| 19 | [Metabolic disorders in children with urolithiasis]. | 2000 | 1 |
| 20 | 2025 | 0 |
About Daniel Finke
Daniel Finke is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Oncology, Public Health, Environmental and Occupational Health and Surgery, having authored 21 papers that have together received 411 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Peptidase Inhibition and Analysis (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cardiovascular Function and Risk Factors (3 papers), Epigenetics and DNA Methylation (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Viral Infections and Immunology Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Oncology (185 citations), Cardiology and Cardiovascular Medicine (148 citations), Cancer Research (49 citations), Radiology, Nuclear Medicine and Imaging (71 citations) and Surgery (84 citations). Daniel Finke has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Lorenz Lehmann, Markus Heckmann, Hugo A. Katus, Florian Leuschner, Uwe Haberkorn, Norbert Frey, Esther Herpel, Hauke Hund, Johannes Backs and S Banavali. Their work appears in journals such as ESC Heart Failure, Clinical Research in Cardiology, Journal of Molecular and Cellular Cardiology, Frontiers in Cardiovascular Medicine and Cytometry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.